These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16840409)

  • 41. An update on emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokine serum profiles in allergic and non-allergic asthma. Increased production of IL-10 by non-allergic asthmatic patients.
    Sánchez-Guerrero I; Vegara RP; Herrero N; García-Alonso AM; Luna A; Alvarez MR
    Allergol Immunopathol (Madr); 1997; 25(2):98-103. PubMed ID: 9150841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokines and their receptors as therapeutic targets in asthma.
    Pauwels RA; Brusselle GG; Tournoy KG; Lambrecht BN; Kips JC
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():1-5. PubMed ID: 9756180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dupilumab for the treatment of asthma.
    Santini G; Mores N; Malerba M; Mondino C; Anzivino R; Macis G; Montuschi P
    Expert Opin Investig Drugs; 2017 Mar; 26(3):357-366. PubMed ID: 28085503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of CD23 in the chronic inflammatory response in asthma: a role for interferon-gamma and heat shock protein 70 in the TH2 environment.
    Harkins MS; Moseley PL; Iwamoto GK
    Ann Allergy Asthma Immunol; 2003 Dec; 91(6):567-74. PubMed ID: 14700442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting airway inflammation: novel therapies for the treatment of asthma.
    Walsh GM
    Curr Med Chem; 2006; 13(25):3105-11. PubMed ID: 17073650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma.
    Corry DB; Kheradmand F
    Am J Respir Med; 2002; 1(3):185-93. PubMed ID: 14720056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma.
    Peters MC; Wenzel SE
    Lancet; 2020 Feb; 395(10221):371-383. PubMed ID: 32007172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-IL-4/-13 based therapy in asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asthma phenotypes and endotypes.
    Lin TY; Poon AH; Hamid Q
    Curr Opin Pulm Med; 2013 Jan; 19(1):18-23. PubMed ID: 23114560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. When one plus one means more than two: the blockade of both IL-4 and IL-13 inflammatory pathways with dupilumab in a case of severe refractory T2-high asthma.
    Sofia C; Simonetti J; Boccabella C; Bonini M
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35039340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in immunopharmacology of asthma.
    Wong WS; Koh DS
    Biochem Pharmacol; 2000 Jun; 59(11):1323-35. PubMed ID: 10751541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease.
    Holgate ST
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):152-7. PubMed ID: 15588688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine-directed therapy in asthma.
    Ichinose M; Barnes PJ
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted anti-IL-13 therapies in asthma: current data and future perspectives.
    Ntontsi P; Papathanassiou E; Loukides S; Bakakos P; Hillas G
    Expert Opin Investig Drugs; 2018 Feb; 27(2):179-186. PubMed ID: 29334288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effects of anti-B7-H3 antibody in an ovalbumin-induced mouse asthma model.
    Chen ZR; Zhang GB; Wang YQ; Yan YD; Zhou WF; Zhu C; Chen Y; Wang J; Ji W
    Ann Allergy Asthma Immunol; 2013 Oct; 111(4):276-81. PubMed ID: 24054363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asthma: pathogenesis and novel drugs for treatment.
    Olin JT; Wechsler ME
    BMJ; 2014 Nov; 349():g5517. PubMed ID: 25420994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies for the treatment of asthma.
    Catley MC; Coote J; Bari M; Tomlinson KL
    Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Anti-inflammatory and anti-allergic effects of acidic fraction of Pheratima extract in asthma mice induced by ovalbumin].
    Zhou MM; Chu XP; Yang HZ; Kou F; Zhao AH; Jia W
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2249-52. PubMed ID: 19166019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disturbed cytokine production at the systemic level in difficult-to-control atopic asthma: evidence for raised interleukin-4 and decreased interferon-γ release following lipopolysaccharide stimulation.
    Manise M; Schleich F; Quaedvlieg V; Moermans C; Henket M; Sele J; Corhay JL; Louis R
    Int Arch Allergy Immunol; 2012; 158(1):1-8. PubMed ID: 22205180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.